hiv viral load changes in delta patients.

NLM AIDSLINE HIV viral load changes in Delta patients. Brun-Vezinet F; Delta Virology Group; France, UK, Netherlands
November 30, 1996

3rd Conf Retro and Opportun Infect. 1996 Jan 28-Feb 1;:162. Unique A subset of 230 Delta1 -AZT naive-patients were recruited in 22 selected centers in France, UK and Netherlands for virological studies including viral load quantitation. Quantitative cellular and plasma viremia were performed by a consensus methodology at week -2, 0, 4, 12, 24, 48, 64 and 96. Plasma RNA measurement was assayed by the Monitor Roche Molecular Systems assay on specimens collected twice at baseline, monthly up to W16, every two months until W64, then every four months. Of the 230 patients, 85 had been randomised to Zidovudine (AZT) monotherapy, 73 to AZT + didanosine (ddl) and 72 to AZT + Zalcitabine(ddC). At baseline, the virology subset patients had a mean and a median CD4 cell count of 210 [IQR: 123-280]; 52% were asymptomatic, 31% had ARC and 17% AIDS. Quantitative cellular and plasma viremia were positive in 91% and 61.6% of the patients respectively. Changes in quantitative cultures and RNA viral load will be reported. Antiviral Agents/ADMINISTRATION & DOSAGE/THERAPEUTIC USE CD4 Lymphocyte Count Didanosine/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Drug Therapy, Combination HIV Infections/BLOOD/DRUG THERAPY HIV-1/GENETICS/*ISOLATION & PURIF Human RNA, Viral/BLOOD Zalcitabine/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Zidovudine/ADMINISTRATION & DOSAGE/THERAPEUTIC USE ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine Health group didn't disclose HIV tests, apologizes NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Danish researchers issue statement: "We are not on the brink of an HIV cure"High school coach charged with sexual contact, transmitting HIV
Information in this article was accurate in November 30, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.